| 摘要 |
The invention refers to a synergistic pharmaceutical combination which comprises (a) a first pharmaceutical composition containing cicletanine or a pharmaceutically suitable acid addition salt thereof and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing an antidiabetic or anti-hyperlipidemic active agent or, if desire d and chemically possible, a pharmaceutically suitable acid addition salt or a salt formed with a pharmaceutically suitable base thereof and one or more conventional carrier(s). The pharmaceutical combination is suitable for the prevention or treatment of, among others, diabetes mellitus.
|
